Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Symptomatic management of the neurological, renal and pulmonary manifestations of tuberous sclerosis is essential

    • 31 Accesses

    This is a preview of subscription content, log in to check access.

    Table I
    Table II

    References

    1. 1.

      Krueger DA, Franz DN. Current management of tuberous sclerosis complex. Pediatr Drugs 2008; 10(5): 299–313

    2. 2.

      Curatolo P, Bombardieri R, Jozwiak S. Tuberous sclerosis. Lancet 2008 Aug 23; 372(9639): 657–68

    3. 3.

      Crino PB, Nathanson KL, Henske EP. The tuberous sclerosis complex. N Engl J Med 2006 Sep 28; 355(13): 1345–56

    4. 4.

      Shepherd CW, Gomez MR, Lie JT, et al. Causes of death in patients with tuberous sclerosis. Mayo Clin Proc 1991 Aug; 66(8): 792–6

    5. 5.

      Schwartz RA, Fernández G, Kotulska K, et al. Tuberous sclerosis complex: advances in diagnosis, genetics, and management. J Am Acad Dermatol 2007 Aug; 57(2): 189–202

    6. 6.

      Robertson DM. Ophthalmic manifestations of tuberous sclerosis. Ann N Y Acad Sci 1991; 615: 17–25

    7. 7.

      Mühler EG, Turniski-Harder V, Engelhardt W, et al. Cardiac involvement in tuberous sclerosis. Br Heart J 1994 Dec; 72(6): 584–90

    8. 8.

      Takayanagi M, Yamamoto K, Nakagawa H, et al. Two successful cases of bromide therapy for refractory symptomatic localization-related epilepsy. Brain Dev 2002 Apr; 24(3): 194–6

    9. 9.

      Hancock E, Osborne J. Vigabatrin in the treatment of infantile spasms in tuberous sclerosis: literature review. J Child Neurol 1999; 14(2): 71–4

    10. 10.

      Goh S, Butler W, Thiele E. Subependymal giant cell tumors in tuberous sclerosis complex. Neurology 2004; 63(8): 1457–61

    11. 11.

      Franz DN, Leonard J, Tudor C, et al. Rapamycin causes regression of astrocytomas in tuberous sclerosis complex. Ann Neurol 2006 Mar; 59(3): 490–8

    12. 12.

      Ewalt D, Sheffield E, Sparagana SP, et al. Renal lesion growth in children with tuberous sclerosis complex. J Urol 1998 Jul; 160(1): 141–5

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Symptomatic management of the neurological, renal and pulmonary manifestations of tuberous sclerosis is essential. Drugs Ther. Perspect 25, 13–15 (2009). https://doi.org/10.2165/0042310-200925060-00004

    Download citation